TEVA PHARMACEUTICAL INDUSTRIES LTD
For the period ended Jun 30, 2025. Filed Jul 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 30, 2025
TEVA$42.97+0.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
| ITEM 5. | OTHER INFORMATION |
|---|
Director and Officer Rule
10b5-1
Trading Arrangements
During the three months ended June 30, 2025, the following officer adopted a
“non-Rule
10b5-1
trading arrangement” (as such term is defined in Item 408 of Regulation
S-K).
| Name and Title | Date | Action | Expiration Date | Maximum SharesSubject to Plan (1) |
|---|---|---|---|---|
| Placid Jover, Executive Vice President, Chief Human Resources Officer | June 9, 2025 | Adopted | August 5, 2025 | 12,827 |
| (1) | The plan includes shares to be sold solely to cover tax withholding obligations. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.